about
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 TatHIV-1 Tat protein mimicry of chemokinesThe guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expressionAspirin, COX-2, and the risk of colorectal cancerIn vitro models of angiogenesis: the use of Matrigel.Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.Angiogenic properties of human immunodeficiency virus type 1 Tat proteinGlycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.Angiogenesis and cancer prevention: a vision.Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.Tumors and inflammatory infiltrates: friends or foes?The angiogenic switch in solid tumors: clinical implications.Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.Neutrophils and angiogenesis: potential initiators of the angiogenic cascade.Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes.Tumor inflammatory angiogenesis and its chemoprevention.The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR.The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration.Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.HIV-1 tat acts as a growth factor and induces angiogenic activity in BK virus/tat transgenic mice.Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach.beta Interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid.The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line.Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization.Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression.Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration.Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent.Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate.
P50
Q22253931-BA9E7FE7-07C7-4FEC-9F8F-CDDCC7EA5D76Q24644383-530CDC60-E501-4D2A-85AD-0AC8A49D0B61Q24671121-658BE313-720D-4D47-9D78-EEB2A7673818Q28219938-9B01E21D-9CAF-40B0-873A-14B86483F30DQ33835187-859A82D6-C66A-4E1C-850F-5760CE840E57Q33923183-FB3D5E57-C980-4780-ACAB-8E0E51E5311DQ34267637-645E895C-E289-4A30-A6B2-2C09BC0766C9Q34528331-E3756985-393C-4D94-A0DD-19672F50EB7FQ34575617-6C6E69DA-8961-4B8C-99DD-7A373CEE1819Q34584781-53F02BE4-BB40-403A-9EFA-6AB1E5288D5EQ34687554-0713C4EB-A894-4C7A-BD2A-86912D552A87Q35092721-DEE22F42-1DDB-48AA-B440-F4D52304B818Q35100546-885AFFAF-A1B8-4BE9-91BB-A66FAFC5AACCQ35208930-5E50B97D-AD43-4737-973E-AE3628F5965DQ35752847-979CFB19-6A0D-4554-B50B-7A20FD4B2274Q35878927-F1FCEAE0-CF12-4AA6-AEFC-00520591E5EFQ36328565-EE61968D-023D-480D-A33A-EE65CA16476BQ38816113-1EC0A88C-69B0-4B08-8444-6C19B600BEA9Q38833469-FC255413-1340-4A12-A331-BDE932234D93Q38873392-E2088B51-DB3C-41AD-88FA-B51FF793B5C1Q39272012-65E0732E-ADB5-4E65-B274-3517BB0E3A72Q39374501-4235F3DA-7524-420D-BCE8-EE844D17280BQ39455141-1F588854-3AC9-4549-876D-D2973787E337Q39951743-34B57B9B-8BE2-4664-971B-A959A573AA9AQ40252845-25D0B226-7A35-4FAE-871A-2049AFBD9836Q40396690-345C5046-09BB-4909-B018-28FE4690E742Q40445269-5BE0E8B1-4BBC-4F41-A72D-42F979802E1FQ40532774-F862EFDF-86A2-414E-93F3-2A97D523DFF2Q40567576-63E12342-2B12-4A6E-B741-603F1FA253A9Q40888776-D32C42FB-C5A6-47F0-9E95-8B8D6C015F90Q41014643-C1FC6320-384E-4222-9A50-237185024BF9Q41247263-A2CBB423-DB93-4C84-AB9A-D0BCB2A9B3C1Q41496600-9963AD64-0A52-4C3B-BFAB-8A768F85B23AQ42181573-7EE27E46-890C-420C-A1F3-5F9E92B24DD8Q42604598-13B2B29C-A62C-4770-93BE-C26971E1F678Q42834555-2B70EA6B-02FF-4D3B-98D7-9E1249386F3DQ43843310-24768CEC-359A-4106-9B38-BB760D5384BAQ43937464-219318EF-7AAD-46B5-A639-16150BD91E7FQ44394568-43A22B02-B564-4674-B099-67EE6F31B482Q44495393-D3EFAF76-7AFD-43A6-9BA0-0FEFC01D2DC7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
R Benelli
@ast
R Benelli
@en
R Benelli
@es
R Benelli
@nl
type
label
R Benelli
@ast
R Benelli
@en
R Benelli
@es
R Benelli
@nl
altLabel
Roberto Benelli
@en
prefLabel
R Benelli
@ast
R Benelli
@en
R Benelli
@es
R Benelli
@nl
P106
P31
P496
0000-0002-9769-0954